Q2 2026 · SEC CIK 0001314620
Hillman Capital Management portfolio
SuperinvestorAsset managerHillman Capital Management, Inc. filed on 2026-08-14. Open SEC filings ↗
- Reported 13F value
- $138.2M
- Reported positions
- 54
- Eligible equities
- 51
- Holdings vs S&P 500, 3 years
- -7.5 pts
Average holding period of the top positions: 4.4 yrs. Holdings vs the S&P 500 over 1 and 5 years: +0.6 pts, -5.6 pts.
In its Q2 2026 13F, filed 2026-08-14, Hillman Capital Management, Inc. reported 54 positions worth $138.2M. Its largest holdings were CVS HEALTH CORP (CVS, 4.2%), BIOGEN INC (BIIB, 3.8%), DUPONT DE NEMOURS INC (DD, 3.7%). Over the last 3 years its top holdings ran 7.5 points a year behind the S&P 500.
Reported holdings in the Q2 2026 13F.
The portfolio weight uses the full reported share-portfolio denominator. Weight changes compare this 13F with the one before it; price moves also change weights, so these are not trade labels. “New” means the position was not in the previous 13F at all; “—” marks a small position the earlier filing data does not cover.
What Hillman Capital Management bought and sold in Q2 2026, against Q1 2026.
New positions
Q1 2026's filing was too long to tell new positions apart.
Added to
- IVV Ishares Tr+27.1% shares
- CRM Salesforce Inc+24.7% shares
- CAG Conagra Brands Inc+22.4% shares
- BDX Becton Dickinson & Co+7.2% shares
- ADBE Adobe Inc+6.7% shares
- CMCSA Comcast Corp New+5.9% shares
Reduced
- TROW Price T Rowe Group Inc-86.1% shares
- TSM Taiwan Semiconductor Manufac-29.6% shares
- ORCL Oracle Corp-28.6% shares
- AKAM Akamai Technologies Inc-28.2% shares
- UNH Unitedhealth Group Inc-27.0% shares
- USB US Bancorp-21.5% shares
- WST West Pharmaceutical Svsc Inc-20.2% shares
- BIIB Biogen Inc-18.8% shares
Left the top 50
- DD Dupont de Nemours Incwas 3.8%
- INTU Intuitwas 0.3%
- GE Ge Aerospacewas 0.3%
- CSGP Costar Group Incwas 0.2%
- SPLG Spdr Series Trustwas 0.2%
Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +19.2% /yr
- S&P 500 +20.1%
- 3 years
- +11.4% /yr
- S&P 500 +20.4%
- 5 years
- +5.5% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Questions about Hillman Capital Management's portfolio
What stocks does Hillman Capital Management own?
Hillman Capital Management, Inc.'s latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 54 positions worth $138.2M. The largest are Cvs Health Corp (CVS) at 4.2%, Biogen Inc (BIIB) at 3.8%, Dupont de Nemours Inc Common Stock (DD) at 3.7%, Warner Bros Discovery Inc (WBD) at 3.7% and Baxter Intl Inc (BAX) at 3.6%.
What did Hillman Capital Management buy last quarter?
In Q2 2026, Hillman Capital Management, Inc. added Ishares Tr (IVV) (+27.1% shares), Salesforce Inc (CRM) (+24.7% shares) and Conagra Brands Inc (CAG) (+22.4% shares), compared with its Q1 2026 filing.
What did Hillman Capital Management sell last quarter?
In Q2 2026, Hillman Capital Management, Inc. cut from its top 50 Dupont de Nemours Inc (DD), cut from its top 50 Intuit (INTU), cut from its top 50 Ge Aerospace (GE), cut from its top 50 Costar Group Inc (CSGP), cut from its top 50 Spdr Series Trust (SPLG), Price T Rowe Group Inc (TROW) (-86.1% shares), Taiwan Semiconductor Manufac (TSM) (-29.6% shares) and Oracle Corp (ORCL) (-28.6% shares), compared with its Q1 2026 filing.
How has Hillman Capital Management's portfolio performed?
A portfolio copying Hillman Capital Management, Inc.'s 20 largest 13F holdings each quarter, from the day each filing was public, returned +11.4% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +19.2% against +20.1%. Over 5 years: +5.5% a year against +11.6%.
When is Hillman Capital Management, Inc.'s next 13F filing due?
13F filings are due 45 days after each quarter ends. Hillman Capital Management, Inc.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Hillman Capital Management, Inc. manage?
Hillman Capital Management, Inc. reported $195.9M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $138.2M.